An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
Mengqi Zhang,Shengxian Bao,Guanhua Qiu,Jingchen Liang,Qin Wang,Xiaoqi Zhu,Guchun Qin,Junjie Liu,Chang Zhao
DOI: https://doi.org/10.2147/BCTT.S387793
2023-02-02
Breast Cancer: Targets and Therapy
Abstract:Mengqi Zhang, 1, &ast Shengxian Bao, 2, &ast Guanhua Qiu, 2, &ast Jingchen Liang, 2 Qin Wang, 2 Xiaoqi Zhu, 2 Guchun Qin, 1 Junjie Liu, 2 Chang Zhao 1 1 Department of Interventional Therapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China; 2 Department of Ultrasound and Department of Radiology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China &astThese authors contributed equally to this work Correspondence: Junjie Liu; Chang Zhao, Email ; Purpose: In this experiment, we constructed a magnetic targeting nano-diagnosis and treatment platform of doxorubicin (DOX) combined with iron nanoparticles, and explored their application value and mechanism in the treatment of Triple Negative Breast Cancer (TNBC), as well as its new diagnosis and treatment mode in Magnetic Resonance Imaging (MRI). Patients and Methods: Hollow mesoporous nanoparticles (HFON) were synthesized by solvothermal method, and loaded the drug DOX () to treat TNBC. The experiments in vivo and in vitro were carried out according to the characteristics of the materials. In vitro experiments, the killing effect of the drug on cells was verified by cell viability CCK8, ROS generation level, LPO evaluation and flow cytometry; the MRI effect and targeted anti-tumor therapy effect were studied by in vivo experiments; then the tumor tissue sections were detected by Ki-67, CD31, ROS, LPO and TUNEL immunofluorescence detection; H&E staining and blood biochemical tests were used to evaluate the biosafety of the materials. Results: Through a series of characterization tests, it is confirmed that the nano-materials prepared in this experiment have positive drug loading properties. MDA-MB-231 cells had great phagocytic ability to under Confocal Laser Scanning Microscope (CLSM). Experiments in vitro confirmed that DOX and Fe were released and concentrated in cells, and a large number of ROS production and induction of LPO were detected by DCFH-DA and C11-BODIPY probes in cells. Apoptosis experiments further confirmed that induced apoptosis, autophagy and ferroptosis. In the vivo experiment, the anti-tumor therapy effect of @HFON group was the most significant, and in MRI also proved that the drug had great tendency and imaging ability in tumor tissue. Conclusion: The new magnetic targeting nano-diagnosis and treatment platform prepared in this experiment is expected to become a new treatment model for TNBC. Keywords: nanoparticles, DOX, Fenton, ROS In recent years, major breakthroughs have been made in cancer treatment research, but the harm caused by cancer still seriously affects human health. Breast Cancer is the most common cancer in women, accounting for approximately 12–14% of all cancer cases worldwide. 1 Among them, TNBC is a special type of breast cancer that is widely known to occur in premenopausal women. It is called TNBC because its Estrogen Receptors, Progesterone Receptors and Human Epidermal Growth Factor Receptor 2 are all negative, The incidence of breast cancer accounts for 15–20% of all subtypes of breast cancer, 2 and the recurrence rate within three years after diagnosis is extremely high. The overall prognosis of TNBC is poor due to the lack of typical molecular targets. For patients, chemotherapy is the only option. 3 As a broad-spectrum antitumor drug, DOX can actively insert into cellular DNA and disrupt topoisomerase II-mediated DNA repair, 4,5 and is currently widely used in breast cancer, osteosarcoma, and lymphoma and other clinical drugs. 6–10 Studies have shown that DOX can also activate Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NADPH Oxidase, NOX) to generate H 2 O 2 . 11,12 Although the effect of DOX in the tumors treatment is considerable, it often causes serious adverse reactions and drug resistance. 13 Therefore, it is a challenging goal to develop new cancer treatment options that can not only effectively fight cancer but also reduce toxic and side effects. The emergence of nanotechnology has attracted great attention of researchers. Nanoparticles are considered to be an important way to selectively increase drug accumulation in tumor cells so as to reduce related side effects. 14,15 Liposome, as a microbubble formed in a lipid-like bilayer structure, can effectively protect drugs from hydrolysis or oxidative degradation by its unique bilayer membrane, thus minimizing toxicity. 16 Liposome drug delivery system has been widely studied to improve the therapeutic effec -Abstract Truncated-